LFB USA Revenue and Competitors
Estimated Revenue & Valuation
- LFB USA's estimated annual revenue is currently $16.1M per year.
- LFB USA's estimated revenue per employee is $155,000
Employee Data
- LFB USA has 104 Employees.
- LFB USA grew their employee count by 8% last year.
LFB USA's People
Name | Title | Email/Phone |
---|---|---|
1 | SVP, Quality | Reveal Email/Phone |
2 | VP Industrial Planning and Supply Management | Reveal Email/Phone |
3 | VP, Finance & IT | Reveal Email/Phone |
4 | Director, Regulatory Affairs | Reveal Email/Phone |
5 | Chief Operating Officer | Reveal Email/Phone |
6 | Sr. Director Finance | Reveal Email/Phone |
7 | Director, QA Compliance | Reveal Email/Phone |
8 | Health And Safety Officer | Reveal Email/Phone |
9 | QA Manager Documentation | Reveal Email/Phone |
10 | Manager Technical Operations | Reveal Email/Phone |
LFB USA Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is LFB USA?
Company Profile\r\n\r\nLFB USA, Inc. is a privately held biotechnology company in the Boston, Massachusetts area with headquarters and laboratories in Framingham, MA and production operations in Charlton, MA. LFB USA is a company within the LFB Group. LFB USA provides development, manufacturing and services to LFB S.A., its sister company rEVO Biologics, and other partners. \r\n\r\nOne of the lead projects of LFB S.A. is the recombinant human Factor FVIIa (LR769) program. LFB USA is responsible for the upstream manufacturing of the recombinant protein and the Clinical and Regulatory aspects of the program. LR769 is currently being evaluated in a Phase 3 study in adults with congenital hemophilia A or B with inhibitors. \r\n\r\nLFB USA’s principal goal is to advance medical care by utilizing its proprietary technology to develop its own programs and assist its partners by providing a full range of services. \r\n\r\nLFB USA is currently looking for motivated scientific, business and healthcare professionals with an entrepreneurial spirit.\r\n\r\nFor more information about LFB USA please visit www.lfb-usa.com\r\n\r\nCompany Background\r\n\r\nLFB USA, Inc. was formed as a subsidiary of LFB Biotechnologies in April, 2014 as the result of a carve-out of rEVO Biologics, Inc.
keywords:N/AN/A
Total Funding
104
Number of Employees
$16.1M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
LFB USA News
Fibrin Market Size 2022-2030| Key Players Csl Behring, Baxter, Johnson & Johnson (ethicon), Lfb Group. Market Size And Forecast. New Jersey, USA,- The...
... Forecast 2022-2030| Key Players CSL Behring, LFB Group, Shanghai RAAS, ... New Jersey, USA,- The research study presented here is a very detailed and...
The United States is further studied across California, Florida, Illinois, ... Lee Biosolutions, Inc, LFB USA, Machaon Diagnostics, Inc.,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15.8M | 105 | 7% | N/A |
#2 | $28.6M | 106 | 8% | N/A |
#3 | $22.7M | 113 | 2% | N/A |
#4 | N/A | 115 | 77% | N/A |
#5 | $38.3M | 116 | 22% | N/A |